Analysts' Actions: SIRI C ED JACK HES BBT

TheStreet.com

NEW YORK (TheStreet) -- CHANGE IN RATINGS

Astea ATEA upgraded to buy at TheStreet Ratings.

Berkshire Hathaway BRK.B upgraded to buy at TheStreet Ratings.

BB&T BBT downgraded at Deutsche from Buy to Hold, Deutsche Bank said. $34 price target. Valuation call, as the stock is up 32% year-to-date.

Ball BLL downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. Valuation call, based on a $44 price target.

Berry Petroleum BRY downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. $38 price target. Core California project has a muted growth outlook.

Citigroup C upgraded at KBW from Market Perform to Outperform, Keefe, Bruyette & Woods said. $44 price target. Fundamentals should improve and the company trades at two-thirds of its tangible book value.

CBOE CBOE downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. $27 price target. Company is facing higher costs and delaying its buyback.

Consolidated Edison ED downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. $60 price target. Company trades at a premium valuation and there are risks surrounding the company's upcoming rate case.

Fidelity National FIS downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. $35 price target. Industry faces long-term growth headwinds.

Fifth Third FITB downgraded at Wells from Outperform to Market Perform, Wells Fargo said. Valuation call, as the company lacks near-term catalysts.

Healthcare Services HCSG downgraded at Benchmark from Buy to Hold, Benchmark said. Valuation call, based on a $23.50 price target.

Hess HES downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. Company faces capital efficiency concerns. $60 price target.

IDEX Corporation IEX downgraded at Oppenheimer to Perform from Outperform, Oppenheimer said. Lower organic growth prospects.

Informatica INFA downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. $31 price target. Company will struggle to achieve 2013 earnings expectations.

Jack in the Box JACK downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. Stock has made a big run versus its peers. $26 price target.

KB Home KBH downgraded at Citigroup to Sell from Neutral, Citigroup said. $12 price target. Agressive valuation considering leverage.

Knight Transportation KNX downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. $15 price target. Stock will likely lag its peers in the coming quarters.

Lennar LEN upgraded at Citigroup to Neutral from Sell, Citigroup said. $35 price target. Underperformed peers despite above average growth.

Liberty Media LMCA upgraded at Citigroup to Buy from Neutral, Citigroup said. $121 price target. Moving toward hard control of Sirius.

Microchip MCHP upgraded at ThinkEquity from Hold to Buy, ThinkEquity said. $38 price target. Recent acquisitions should add to earnings.

ON Semiconductor ONNN upgraded at ThinkEquity from Hold to Buy, ThinkEquity said. New CFO will drive to improve profitability. $8 price target.

Palo Alto PANW rated new Outperform at JMP. $77 price target. Company can capitalize on explosive demand for next-generation security.

PNC Financial PNC upgraded at Deutsche from Hold to Buy, Deutsche Bank said. $71 price target. Stock has lagged its peers for too long. $71 price target.

SAIC SAI downgraded at JP Morgan from Neutral to Underperform, JP Morgan said. $11 price target. Stock trades at a premium to its peers, even though the company still has to restructure.

Sirius XM SIRI rated new Buy at BofA/Merrill. $3.75 price target. Company can leverage its premier content and growing subscriber base.

Silgan SLGN downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. $44 price target. Stock should lag its peers in the coming quarters.

Safeway SWY downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. $15 price target. Expect the company to lag its peers in the coming quarters.

Integrys Energy TEG upgraded at DA Davidson from Neutral to Buy, DA Davidson said. $59 price target. Asset purchase should boost the rate base.

Tyler Technologies TYL rated new Buy at ThinkEquity. $50 price target. Company is a market leader and can continue to gain market share.

Valmont VMI downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. Valuation call, based on a $123 price target.

Wells Fargo WFC downgraded at Deutsche from Buy to Hold, Deutsche Bank said. $36 price target. Valuation call, as the stock is up 25% year-to-date.

WR Berkley WRB downgraded at Goldman to Sell, Goldman Sachs said. Valuation call, based on a $35 price target.

STOCK COMMENTS / EPS CHANGES

ARIAD Pharma ARIA target raised at Jefferies to $28, Jefferies said. Early AP26113 efficacy data encouraging. Buy rating.

Anheuser-Busch InBev BUD added to Key Call List at UBS. US top line momentum with margin upside. $94.06 price target.

Celanese CE numbers cut at UBS. Shares of CE now seen reaching $47, UBS said. Estimates also lowered on new growth guidance.

Generac GNRC estimates, target raised at BMO. Shares of GNRC now seen reaching $30, according to BMO Capital. Estimates also increased, given large power outages. Outperform rating.

International Paper IP numbers reduced at BMO. IP estimates were cut through 2013, BMO Capital said. Company is discounting more and seeing lower demand for pulp.

Kronos Worldwide KRO numbers lowered at Oppenheimer. Shares of KRO now seen reaching $20, Oppenheimer said. Estimates also lowered on ugly pre-announcement. Outperform rating.

Pentair PNR numbers raised at Oppenheimer. Shares of PNR now seen reaching $46, Oppenheimer said. Estimates also raised on merger possibilities. Perform rating.

Travelers TRV cut from Conviction Buy List at Goldman. Valuation call, based on a $75 price target.

STRATEGY CALLS / MARKET CALLS

MedTech sector upgraded at BMO. Medical Technology sector was upgraded from Market Perform to Outperform, BMO Capital said. End-markets are stabilizing and expectations appear reasonable. BAX, MDT, STJ and ZMH are among the analyst's top picks.

>To submit a news tip, email: tips@thestreet.com.

READERS ALSO LIKE:


Follow TheStreet on Twitter and become a fan on Facebook.

For less than $3 per week, you can get full access to Jim Cramer's intraday market commentary and stock trading strategies - sometimes before he says them on TV! Join now.

Rates

View Comments (0)